Sign in
4

Changes in Ownership

abrdn Life Sciences Investors Filed Acc 0001104659-14-049754

Director bought 200 shares at $19.75 ($3,950)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
REARDON WILLIAM S Director 2014-06-30 Purchase +200 $19.75 $3,950 1,612 D
Open-market purchases · 200 sh · avg $19.75 · $3,950
Loading xslF345X03/a4.xml…